Clinical recovery and circulating botulinum toxin type F in adult patient.
A 56-year-old woman in Helena, Montana, USA, who showed clinical signs of paralysis, received antitoxins to botulinum toxins A, B, and E within 24 hours; nevertheless, symptoms progressed to complete quadriplegia. On day 8, she began moving spontaneously, even though blood tests later showed botulinum toxin type F remained.
Sobel
Jeremy
J
Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. jsobel@cdc.gov
Dill
Tracy
T
Kirkpatrick
Christina L
CL
Riek
Laurel
L
Luedtke
Patrick
P
Damrow
Todd A
TA
D000818:Animals; D001904:Botulinum Antitoxin / Q000008:administration & dosage / Q000627:therapeutic use*; D001905:Botulinum Toxins / Q000097:blood* / Q000506:poisoning*; D001906:Botulism / Q000188:drug therapy* / Q000473:pathology; D003013:Clostridium / Q000145:classification / Q000302:isolation & purification; D004638:Emergency Treatment; D005243:Feces / Q000382:microbiology; D005260:Female; D006801:Humans; D051379:Mice; D008875:Middle Aged; D012121:Respiration, Artificial; D016896:Treatment Outcome
D001904:Botulinum Antitoxin; D001905:Botulinum Toxins; C096321:botulinum toxin type F